loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate in Europe. Original Data : EMA Website

Menu
$ API Ref.Price (USD/KG) : 117Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Accord Healthcare B.V.

02 2Accord Healthcare Ltd.

03 17Adamed Sp. z.o.o.

04 2Aurobindo Pharma Ltd.,

05 2Bluefish Pharmaceuticals AB

06 4Boehringer Ingelheim

07 2Jubilant Pharmaceuticals NV

08 2KRKA Sweden AB

09 2Mylan AB

10 2Pfizer

11 2STADA Arzneimittel AG

12 2Sandoz A / S,

13 1Sandoz A/S

14 2Teva Sweden AB

15 1Upjohn EESV

16 3Vitabalans Oy

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Perindopril

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 4MG; 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

02

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Perindopril

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 4MG; 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

03

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Perindopril

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 8MG; 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

04

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Perindopril

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 8MG; 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

05

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Candesartan Cilexetil

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 8MG; 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

06

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Candesartan Cilexetil

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 8MG; 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

07

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Candesartan Cilexetil

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 16MG; 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

08

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Candesartan Cilexetil

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 16MG; 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

09

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Ramipril

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 2.5MG; 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

10

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Amlodipine Besylate; Ramipril

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 5MG; 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank